News and reflections from the world of AI

Aiforia and X-ZELL partner to scale up novel AI-powered method for early cancer detection

Singapore, Helsinki -- Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis, and X-ZELL, a clinical stage med-tech company aiming to make early, affordable cancer detection accessible to everyone, have entered into a strategic partnership to integrate X-ZELL’s novel rare cell detection technology with Aiforia’s deep learning AI software.

5 reasons to use AI in clinical diagnostics

Español, Français Rising rates of disease like cancer increase sample numbers creating a bigger burden on pathologists, an already underrepresented group of healthcare professionals. The challenge is exacerbated by the fact that traditional clinical tools and processes available to pathologists are manual and subjective.

Benefits of AI and digital pathology to the clinical lab: interview with pathologists Dr. Mirtti and Dr. Sandeman

Pathologists have been examining glass slides under a microscope for over 150 years. Only recently did laboratories around the world start digitizing their slides, enabling more efficient workflows and increased accuracy in diagnostics. Adding AI to the newly digitized practice has the potential to increase these benefits exponentially. In this interview pathologists from Sweden and Finland share ...